Today's Daily Dose: Piroxicam
Learn about the potential anticancer effects of piroxicam.
Untitled Document
“The potential anticancer effects of piroxicam in cats with transitional cell carcinoma have not been thoroughly described, but, anecdoctally, piroxicam appears to be well-tolerated at a dosage of 0.3 mg/kg by mouth two or three times a week. Using this dosing scheme in cats with transitional cell carcinoma should be safe based on prior pharmacokinetic studies of oral piroxicam conducted in healthy cats; however, its anticancer effectiveness remains poorly characterized in cancer-bearing cats.”
-Timothy M. Fan, DVM, PhD, DACVIM (internal medicine and oncology)
From Just Ask the Expert: Transitional cell carcinoma of the bladder and piroxicam
Presurgical evaluation and diagnostic imaging for canine mast cell tumors
November 7th 2024Ann Hohenhaus, DVM, DACVIM (Oncology, SAIM), delved into essential components of a diagnostic investigation of dogs with MCRs, including fine-needle aspiration and diagnostic imaging methods during her session at the NY Vet Show in New York, New York
Read More
